Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...
Prophylactic medication after ileocaecal resection in patients with Crohn's disease reduces long-term rates of severe endoscopic recurrence and endoscopic or radiologic recurrence, serving as a ...
The introduction of urate-lowering therapy can affect the risk for gout flares, with fewer flares observed when less intensive treatment and flare prophylaxis were used. The introduction of ...
Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) ...
The RCTs included in this review have assessed a broad range of treatments that resulted in limited opportunities to describe and pool useful data. Studies available for analysis are a highly ...
This activity was supported by Contract Order No. VA 36C24E18C0067 between the National Academy of Sciences and the Department of Veterans Affairs. Any opinions, findings, conclusions, or ...
Medicare may cover full cost of preexposure prophylaxis drugs; rules aim to prevent excessive compensation in Medicare Advantage (MA) market; health officials advocate for widespread syphilis testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results